1
|
Monteiro Bezerra M, Borges S, Vivas I, Rosa J, Uchida J. COGNITIVE DEFICIT AND CARDIOVASCULAR RISK IN COMMUNITY-DWELLING ELDERLY. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.2833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | - S.M. Borges
- Physical Therapy, Santa Cecília University, Cubatão, São Paulo, Brazil
| | - I. Vivas
- Physical Therapy, Santa Cecília University, Cubatão, São Paulo, Brazil
| | - J. Rosa
- Physical Therapy, Santa Cecília University, Cubatão, São Paulo, Brazil
| | - J.E. Uchida
- Physical Therapy, Santa Cecília University, Cubatão, São Paulo, Brazil
| |
Collapse
|
2
|
Borges S, Monteiro Bezerra M, Rosa J, Uchida J. FRAILTY SYNDROME IN OLDER ADULTS WITH AND WITHOUT FEAR OF FALLING. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.4131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- S.M. Borges
- Santa Cecília University, Santos, Sao Paulo, Brazil
| | | | - J. Rosa
- Santa Cecília University, Santos, Sao Paulo, Brazil
| | - J.E. Uchida
- Santa Cecília University, Santos, Sao Paulo, Brazil
| |
Collapse
|
3
|
Rosa J, Monteiro Bezerra M, Uchida J, Borges S. SHORT PHYSICAL PERFORMANCE BATTERY DIFFERENCES BETWEEN PHYSICALLY ACTIVE AND SEDENTARY OLDER ADULTS. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- J. Rosa
- student, Universidade Santa Cecília, Santos, São Paulo, Brazil
| | | | - J.E. Uchida
- student, Universidade Santa Cecília, Santos, São Paulo, Brazil
| | - S.M. Borges
- student, Universidade Santa Cecília, Santos, São Paulo, Brazil
| |
Collapse
|
4
|
Silva AAR, Bezerra MM, Chaves HV, Pereira KMA, Aguiar JA, Pinto VPT, Abbet C, Simões-Pires CA, Franco ES, Henriques AT, Hostettmann K, Maia MBS. Protective effect of Chresta martii extract against indomethacin-induced gastric lesions in mice. J Nat Med 2012; 67:143-51. [PMID: 22450730 DOI: 10.1007/s11418-012-0663-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2012] [Accepted: 03/12/2012] [Indexed: 10/28/2022]
Abstract
Chresta martii (Asteraceae) is a plant found in the Xingó region (semi-arid area) in Northeastearn Brazil, and is recognized by the local population as a traditional herb used to treat gastric diseases. This is the first report of the chemical composition, acute toxicity, and gastroprotective effect in mice of the hydroalcoholic extract (HAE) from the aerial parts (leaves and flowers) of Chresta martii. Animals received HAE doses from 10 to 2000 mg/kg, i.p. or 50 to 3000 mg/kg, p.o.) and were observed over 48 h for toxicity signs and mortality; sub-chronic toxicity was evaluated through 14 days treatment with once-daily HAE doses (400 mg/kg, p.o.). The gastroprotective effect of HAE was demonstrated on the indomethacin-induced gastric ulcer model after the administration of extracts. Data comparison of ulcer index averages between saline and HAE (100 or 400 mg/kg, p.o.) groups showed significant (P < 0.01) inhibition (71.73 and 76.72 %, respectively) of indomethacin-induced gastric lesions. Histological analyses showed significant (P < 0.05) inhibition of leukocyte migration in HAE-treated groups. A fingerprint of the HAE obtained by HPLC/UV/MS analysis showed major peaks characteristic of sesquiterpene lactones. Compound 1 was isolated and elucidated as a new natural product. Its capacity to prevent leukocyte chemotaxis was demonstrated in vitro, corroborating the pharmacological effects observed for C. martii HAE.
Collapse
Affiliation(s)
- A A R Silva
- Federal University of Ceará Brazil, Avenida Comandante Maurocélio Rocha Pontes, Sobral, Brazil.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
de Moraes MEA, Bezerra MM, Bezerra FAF, de Moraes RA, Cavalcanti PP, Uchoa CRA, Lima FAV, Odorico de Moraes M. Safety evaluation of Elixir paregorico® in healthy volunteers: a phase I study. Hum Exp Toxicol 2008; 27:751-6. [DOI: 10.1177/0960327108090274] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
A liquid alcoholic extract of Papaver somniferum named Elixir Paregorico® is extensively used for diarrheal diseases in Brazil. Its increased popularity has brought concerns and fears over the safety of this herbal product. Given the lack of investigative clinical studies, in this regard, this study investigated whether Elixir Paregorico® administration causes any noticeable toxic effects in healthy volunteers. In all, 28 middle-aged healthy male ( n = 14) and female ( n = 14) were enrolled. After screening and a washout period, eligible subjects received four oral doses per day of Elixir Paregorico® (3 mL diluted in 30 mL of water) over a 10-day period. Altogether, all 28 participants completed the study. The results of hematological and biochemical tests performed pre and post-treatment were within the normal range. In both male and female volunteers, there were no statistical differences ( P > 0.05) in the results of clinical and laboratory tests performed at screening, on 5th and 10th day visits, and at final assessment. Although mild adverse events were related, which subsided spontaneously, no serious untoward reactions were reported following Elixir Paregorico® administration. To our knowledge, this is the first demonstration that Elixir Paregorico® administered four times a day for 10 days is safe and does not cause any noticeable toxic effect in healthy volunteers.
Collapse
Affiliation(s)
- MEA de Moraes
- Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil
| | - MM Bezerra
- Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil
| | - FAF Bezerra
- Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil
| | - RA de Moraes
- Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil
| | - PP Cavalcanti
- Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil
| | - CRA Uchoa
- Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil
| | - FAV Lima
- Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil
| | - M Odorico de Moraes
- Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil
| |
Collapse
|
6
|
Barroso AB, Lima V, Guzzo GC, Moraes RA, Vasconcellos MC, Bezerra MM, Viana FAL, Bezerra RCR, Santana GSM, Frota-Bezerra FA, Moraes MO, Moraes MEA. Efficacy and safety of combined piroxicam, dexamethasone, orphenadrine, and cyanocobalamin treatment in mandibular molar surgery. Braz J Med Biol Res 2006; 39:1241-7. [PMID: 16981050 DOI: 10.1590/s0100-879x2006000900012] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2005] [Accepted: 07/17/2006] [Indexed: 11/22/2022] Open
Abstract
Third molar extraction is a common procedure frequently accompanied by moderate or severe pain, and involves sufficient numbers of patients to make studies relatively easy to perform. The aim of the present study was to determine the efficacy and safety of the therapeutic combination of 10 mg piroxicam, 1 mg dexamethasone, 35 mg orphenadrine citrate, and 2.5 mg cyanocobalamin (Rheumazin) when compared with 20 mg piroxicam alone (Feldene) in mandibular third molar surgery. Eighty patients scheduled for removal of the third molar were included in this randomized and double-blind study. They received (vo) Rheumazin or Feldene 30 min after tooth extraction and once daily for 4 consecutive days. Pain was determined by a visual analogue scale and by the need for escape analgesia (paracetamol). Facial swelling was evaluated with a measuring tape and adverse effects and patient satisfaction were recorded. There was no statistically significant difference in facial swelling between Rheumazin and Feldene (control group). Both drugs were equally effective in the control of pain, with Rheumazin displaying less adverse effects than Feldene. Therefore, Rheumazin appears to provide a better risk/benefit ratio in the mandibular molar surgery. Since the side effects resulting from nonsteroidal anti-inflammatory drug administration are a severe limitation to the routine use of these drugs in clinical practice, our results suggest that Rheumazin can be a good choice for third molar removal treatment.
Collapse
Affiliation(s)
- A B Barroso
- Unidade de Farmacologia Clínica, Departamento de Fisiologia e Farmacologia, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE, Brasil
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Abstract
Matrix metalloproteinases (MMP) are considered to be key initiators of collagen degradation, thus contributing to bone resorption in inflammatory diseases. We determined whether subantimicrobial doses of doxycycline (DX) (< or =10 mg kg-1 day-1), a known MMP inhibitor, could inhibit bone resorption in an experimental periodontitis model. Thirty male Wistar rats (180-200 g) were subjected to placement of a nylon thread ligature around the maxillary molars and sacrificed after 7 days. Alveolar bone loss (ABL) was measured macroscopically in one hemiarcade and the contralateral hemiarcade was processed for histopathologic analysis. Groups of six animals each were treated with DX (2.5, 5 or 10 mg kg-1 day-1, sc, 7 days) and compared to nontreated (NT) rats. NT rats displayed significant ABL, severe mononuclear cell influx and increase in osteoclast numbers, which were significantly reduced by 5 or 10 mg kg-1 day-1 DX. These data show that DX inhibits inflammatory bone resorption in a manner that is independent of its antimicrobial properties.
Collapse
Affiliation(s)
- M M Bezerra
- Departamento de Fisiologia e Farmacologia, Faculdade de Medicina, Universidade Federal do Ceará, Rua Cel. Nunes de Melo 1127, 60430-270 Fortaleza, CE, Brazil
| | | | | | | |
Collapse
|
8
|
Bezerra MM, de Lima V, Alencar VB, Vieira IB, Brito GA, Ribeiro RA, Rocha FA. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000; 71:1009-14. [PMID: 10914805 DOI: 10.1902/jop.2000.71.6.1009] [Citation(s) in RCA: 122] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
BACKGROUND Prostaglandins are implicated in periodontal bone destruction. We investigated the effect of a non-selective cyclooxygenase (COX) inhibitor (indomethacin-IND) or a type 2 COX inhibitor (meloxicam-MLX) in an experimental periodontal disease (EPD) model. METHODS Wistar rats were subjected to placement of a nylon thread ligature around the maxillary molars and sacrificed after 7 days. Alveolar bone loss (ABL) was measured in one quadrant as the distance between the cemento-enamel junction and the alveolar bone. The other quadrant was processed for histopathologic analysis. Daily weight and white blood cell count were recorded. Groups were treated subcutaneously for 7 days with either IND (0.5, 1, or 2 mg/kg) or MLX (0.75, 1.5, or 3 mg/kg). Controls received no treatment. Macroscopic analysis of the gastric mucosa was done. The control group did not receive any manipulation, and a non-treated group consisted of rats subjected to periodontitis that received no pharmacological treatment. RESULTS In the non-treated (NT) group, there was significant ABL, severe mononuclear influx, and an increase in osteoclast numbers. Significant neutrophilia and lymphomonocytosis occurred at 6 hours and at 7 days, respectively, as compared to controls. Significant weight loss persisted until the seventh day in the NT group. Both IND and MLX reduced ABL and histopathologic changes. Neutrophilia and lymphomonocytosis were also significantly reversed. Both IND and MLX induced earlier weight recovery. The stomachs of the IND (1 and 2 mg/kg) groups presented hemorrhage and ulcers, whereas in the MLX-treated groups, there were mild petechiae just in the 3 mg/kg group. CONCLUSIONS COX inhibition prevented ABL in this experimental periodontal disease model. MLX displays similar efficacy and less gastric damage than IND. MLX may provide a better risk/benefit ratio in the treatment of human periodontitis than non-selective COX inhibitors.
Collapse
Affiliation(s)
- M M Bezerra
- Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil
| | | | | | | | | | | | | |
Collapse
|
9
|
de Lima V, Bezerra MM, de Menezes Alencar VB, Vidal FD, da Rocha FA, de Castro Brito GA, de Albuquerque Ribeiro R. Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in rats. Eur J Oral Sci 2000; 108:123-9. [PMID: 10768725 DOI: 10.1034/j.1600-0722.2000.00766.x] [Citation(s) in RCA: 85] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Chlorpromazine (CPZ), a phenothiazine derivative, possesses anti-inflammatory properties, inhibition of tumor neurosis factor-alpha (TNF-alpha) synthesis and bone resorption. TNF-alpha promotes inflammatory changes and bone resorption in periodontitis. We have studied the effect of CPZ in experimental periodontitis. Wistar rats were subjected to a ligature placement around the cervix of the right second upper molars. Alveolar bone loss was evaluated by the sum of the distances between the cusp tip and the alveolar bone along the axis of each molar root, which was subtracted from the contralateral side. Histopathological analysis of the periodontium was based on cell influx, osteoclast number, and alveolar bone and cementum integrity. Animals were weighed daily and total and differential peripheral white blood cell counts were performed 6 h and 1, 7 and 11 d after periodontitis induction. Groups were treated with CPZ 1 h before and daily up to the 11th d of periodontitis. Alveolar bone loss was inhibited 46%, 55.4%, and 76.5% by CPZ at 1, 3 and 9 mg/kg, respectively. Histological analysis showed a significant reduction of cell influx and osteoclast number, as well as preservation of the alveolar process and cementum. CPZ reversed leukocytosis but not weight loss. In conclusion, CPZ reduces bone loss in experimental periodontitis, probably via TNF-alpha blockade.
Collapse
Affiliation(s)
- V de Lima
- Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil
| | | | | | | | | | | | | |
Collapse
|
10
|
Abstract
Qualification for nursing professionals is important for they deal with lives that need qualified care. This study aims at analysing health professionals opinions about nursing attendants. It was accomplished between March and July, 1997. Nurses, physicians, nursing aids and technicians at public and philanthropic hospitals in Fortaleza--CE were interviewed. The outcomes show that nursing attendants, most times, perform the same procedures as the nursing aids and may interfere with the provided service quality and cause iatrogenics; others consider them as important at institutions for their practice; some others express themselves completely against the non-qualified professionalization process; anothers express themselves for this process, but disagree on how it is accomplished for they do not perceive any change in their professional profile after being qualified. We do understand that this question is deserving of immediate attitudes for it is related to nursing principal subject: Caring.
Collapse
|
11
|
Bezerra MM, Cremonesi E, Bairão GS. [Utilization of metho-hexital sodium in anesthesia for peroral endoscopy]. Rev Bras Anestesiol 1966; 16:176-80. [PMID: 5942221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
|